Vaccine Information Statements (VIS) - Immunization Unit

Vaccine Information Statements (VIS) are information sheets produced by the Centers for Disease Control and Prevention (CDC) that explain to vaccine recipients, their parents, or their legal representatives both the benefits and risks of a vaccine.

Under the National Childhood Vaccine Injury Act (NCVIA), federal law requires that VIS be handed out whenever certain vaccinations are given. Instructions for the use of VIS and record-keeping can be viewed on the Centers for Disease Control & Prevention website. Providers should review current CDC requirements for record-keeping. An optional consent form template is provided as an addendum to each VIS below.  

For all questions pertaining to the literature list or order form, please call Immunizations Unit at (800) 252-9152.

NOTE: Federal law allows for VIS to be used for six months after the release of a revised VIS, unless the CDC states the new VIS should be used immediately. 

Table of Contents

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |

Anthrax

Vaccine Information Statements and Addendums Relating to the Anthrax vaccine
Stock Number Title Revision
EF11-11161 Anthrax VIS - English (PDF) 01/2020
EF11-11161-add Anthrax VIS Addendum - English (PDF) 03/2010
EF11-11161A Anthrax VIS - Spanish (PDF) 03/2010
EF11-11161A-sup Anthrax VIS Addendum - Spanish (PDF) 03/2010

Varicella (Chickenpox)

Vaccine Information Statements and Addendums Relating to the Varicella (Chickenpox) vaccine
Stock Number Title Revision
C-97 Varicella (Chickenpox) Vaccine VIS: English (PDF) 08/06/2021
C-97-add Varicella (Chickenpox) Vaccine VIS Addendum: English (PDF) 08/2021
C-97A Varicella (Chickenpox) Vaccine VIS: Spanish (PDF) 08/06/2021
C-97A-sup Varicella (Chickenpox) Vaccine VIS Addendum: Spanish (PDF) 08/2021

DTaP (Diphtheria, Tetanus, & Pertussis)

Vaccine Information Statements and Addendums Relating to the DTaP (Diphtheria, Tetanus, & Pertussis) vaccines
Stock Number Title Revision
C-91 DTaP (Diphtheria, Tetanus, & Pertussis) Vaccine VIS: English (PDF) 08/06/2021
C-91-add DTaP (Diphtheria, Tetanus, & Pertussis) Vaccine VIS Addendum: English (PDF) 08/2021
C-91A DTaP (Diphtheria, Tetanus, & Pertussis) Vaccine VIS: Spanish (PDF) 08/06/2021
C-91A-sup DTaP (Diphtheria, Tetanus, & Pertussis) Vaccine VIS Addendum: Spanish (PDF) 08/2021

Haemophilus influenzae type b (Hib)

Vaccine Information Statements and Addendums Relating to the Haemophilus influenzae type b (Hib) vaccine
Stock Number Title Revision
C-108 Haemophilus influenzae type b (Hib) VIS: English (PDF) 08/06/2021
C-108-add Haemophilus influenzae type b (Hib) VIS Addendum: English (PDF) 08/2021
C-108A Haemophilus influenzae type b (Hib) VIS Spanish (PDF) 08/06/2021
C-108A-sup Haemophilus influenzae type b (Hib) VIS Addendum: Spanish (PDF) 08/2021

Hepatitis A

Vaccine Information Statements and Addendums Relating to the Hepatitis A vaccine
Stock Number Title Revision
C-95 Hepatitis A Vaccine VIS: English (PDF) 10/15/2021
C-95-add Hepatitis A  Vaccine VIS Addendum: English (PDF) 10/2021
C-95A Hepatitis A Vaccine VIS: Spanish (PDF) 10/15/2021
C-95A-sup Hepatitis A Vaccine VIS Addendum: Spanish (PDF) 10/15/2021

Hepatitis B

Vaccine Information Statements and Addendums Relating to the Hepatitis B vaccine
Stock Number Title Revision
C-106 Hepatitis B Vaccine VIS: English (PDF) 10/15/2021
C-106-add Hepatitis B Vaccine VIS Addendum: English (PDF) 10/2021
C-106A Hepatitis B Vaccine VIS: Spanish (PDF) 10/15/2021
C-106A-sup Hepatitis B Vaccine VIS Addendum: Spanish (PDF) 10/15/2021


HPV (Human Papillomavirus) Vaccine

Vaccine Information Statements and Addendums Relating to the HPV (Human Papillomavirus) Vaccine
Stock Number Title Revision
C-116 HPV (Human Papillomavirus) Vaccine VIS: English (PDF) 08/06/2021
C-116-add HPV (Human Papillomavirus) Vaccine VIS Addendum: English (PDF) 08/2021
C-116A HPV (Human Papillomavirus) Vaccine - VIS: Spanish (PDF) 08/06/2021
C-116A-sup HPV (Human Papillomavirus) Vaccine - VIS Addendum: Spanish (PDF) 08/2021

Inactivated Influenza VIS

Vaccine Information Statements and Addendums Relating to the Inactivated Influenza VIS vaccine
Stock Number Title Revision
C-93 Influenza (Flu) Vaccine (Inactivated or Recombinant) VIS: English (PDF) 08/06/2021
C-93-add Influenza (Flu) Vaccine (Inactivated or Recombinant) VIS Addendum: English (PDF)
 08/2021
C-93A Influenza (Flu) Vaccine (Inactivated or Recombinant) VIS: Spanish (PDF)
 08/06/2021
C-93A-sup Influenza (Flu) Vaccine (Inactivated or Recombinant) VIS Addendum: Spanish (PDF)
 08/2021

Influenza (Flu) Vaccine (Live, Intranasal)

Vaccine Information Statements and Addendums Relating to the Influenza (Flu) Vaccine (Live, Intranasal)
Stock Number Title Revision
C-87 Influenza (Flu) Vaccine (Live, Intranasal) VIS: English (PDF)
 08/06/2021
C-87-add Influenza (Flu) Vaccine (Live, Intranasal) VIS Addendum: English (PDF)
 08/2021
C-87A Influenza (Flu) Vaccine (Live, Intranasal) VIS: Spanish (PDF)
 08/06/2021
C-87A-sup Influenza (Flu) Vaccine (Live, Intranasal) VIS Addendum: Spanish (PDF) 
 08/2021

Japanese Encephalitis (IXIARO)

Vaccine Information Statements and Addendums Relating to the Japanese Encephalitis (IXIARO) vaccine
Stock Number Title Revision
EF11-13431 Japanese Encephalitis (IXIARO) VIS - English (PDF) 08/2019
EF11-13431-add Japanese Encephalitis (IXIARO) VIS Addendum - English (PDF) 12/2011
EF11-13431A Japanese Encephalitis (IXIARO) VIS - Spanish (PDF) 01/2014
EF11-13431-sup Japanese Encephalitis (IXIARO) VIS Addendum - Spanish (PDF) 03/2010

MMR Vaccine (Measles, Mumps, & Rubella)

Vaccine Information Statements and Addendums Relating to the MMR Vaccine (Measles, Mumps, & Rubella) (MMR)
Stock Number Title Revision
C-92 MMR Vaccine (Measles, Mumps, & Rubella) VIS: English (PDF) 08/06/2021
C-92-add MMR Vaccine (Measles, Mumps, & Rubella) VIS Addendum: English (PDF) 08/2021
C-92A MMR Vaccine (Measles, Mumps, & Rubella) VIS: Spanish (PDF) 08/06/2021
C-92A-sup MMR Vaccine (Measles, Mumps, & Rubella) VIS Addendum: Spanish (PDF) 08/2021

MMRV Vaccine (Measles, Mumps, Rubella, & Varicella)

Vaccine Information Statements and Addendums Relating to the MMRV Vaccine (Measles, Mumps, Rubella, & Varicella) (MMRV)
Stock Number Title Revision
C-115 MMRV Vaccine (Measles, Mumps, Rubella, & Varicella) VIS: English (PDF) 08/06/2021
C-115-add MMRV Vaccine (Measles, Mumps, Rubella, & Varicella) VIS Addendum: English (PDF) 08/2021
C-115A MMRV Vaccine (Measles, Mumps, Rubella, & Varicella) VIS: Spanish (PDF) 08/06/2021
C-115A-sup MMRV Vaccine (Measles, Mumps, Rubella, & Varicella) VIS Addendum: Spanish (PDF) 08/2021

Meningococcal ACWY Vaccine

Vaccine Information Statements and Addendums Relating to the Meningococcal ACWY vaccine
Stock Number Title Revision
C-96 Meningococcal ACWY Vaccine VIS: English (PDF) 08/06/2021
C-96-add Meningococcal ACWY Vaccine VIS Addendum: English (PDF) 08/2021
C-96A Meningococcal ACWY Vaccine VIS: Spanish (PDF) 08/06/2021
C-96A-sup Meningococcal ACWY Vaccine VIS Addendum: Spanish (PDF) 08/2021

Meningococcal B Vaccine

Vaccine Information Statements and Addendums Relating to the Meningococcal B vaccine
Stock Number Title Revision
C-117 Meningococcal B Vaccine VIS: English (PDF) 08/06/2021
C-117-add Meningococcal B Vaccine VIS Addendum: English (PDF) 08/2021
C-117A Meningococcal B Vaccine Interim VIS: Spanish (PDF) 08/06/2021
C-117A-sup Meningococcal B Vaccine Interim VIS Addendum: Spanish (PDF) 08/2021

Multiple Vaccines (DTap, HiB, Hepatitis B, Polio, and PCV13)

Vaccine Information Statements and Addendums Relating to Your Child's First Vaccines: Multi Pediatric Vaccines Administered at Once
Stock Number Title Revision
C-113 Your Child's First Vaccines: Multi Pediatric Vaccines VIS: English (PDF) 10/15/2021
C-113-add Your Child's First Vaccines: Multi Pediatric Vaccines VIS Addendum: English (PDF) 10/2021
C-113A Your Child's First Vaccines: Multi Pediatric Vaccines VIS: Spanish (PDF) 10/15/2021
C-113A-sup Your Child's First Vaccines: Multi Pediatric Vaccines VIS Addendum: Spanish (PDF) 10/15/2021

Pneumococcal Conjugate (PCV) Vaccine

Vaccine Information Statements and Addendums Relating to the Pneumococcal Conjugate vaccine
Stock Number Title Revision
C-85 Pneumococcal Conjugate (PCV13) Vaccine Interim VIS: English (PDF) 02/04/2022
C-85-add Pneumococcal Conjugate (PCV13) Vaccine Interim VIS Addendum: English (PDF) 02/04/2022
C-85A Pneumococcal Conjugate (PCV13) Vaccine VIS: Spanish (PDF) 08/06/2021
C-85A-sup Pneumococcal Conjugate (PCV13) Vaccine VIS Addendum: Spanish (PDF) 08/2021

Pneumococcal Polysaccharide (PPSV 23) Vaccine

Vaccine Information Statements and Addendums Relating to the Pneumococcal Polysaccharide vaccine
Stock Number Title Revision
C-86 Polysaccharide (PPSV 23) Vaccine VIS: English (PDF) 10/30/2019
C-86-add Polysaccharide (PPSV 23) Vaccine VIS Addendum: English (PDF) 10/2019
C-86A Polysaccharide (PPSV 23) Vaccine VIS: Spanish (PDF) 10/30/2019
C-86A-sup Polysaccharide (PPSV 23) Vaccine VIS Addendum: Spanish (PDF) 10/2019

Polio Vaccine

Vaccine Information Statements and Addendums Relating to the Polio vaccine
Stock Number Title Revision
C-90 Polio Vaccine VIS: English (PDF) 08/06/2021
C-90-add Polio Vaccine VIS Addendum: English (PDF) 08/2021
C-90A Polio Vaccine VIS: Spanish (PDF) 08/06/2021
C-90A-sup Polio Vaccine VIS Addendum: Spanish (PDF) 08/2021

Rabies Vaccine

Vaccine Information Statements and Addendums Relating to the Rabies vaccine
Stock Number Title Revision
C-99 Rabies Vaccine VIS: English (PDF) 01/08/2020
C-99-add Rabies Vaccine VIS Addendum: English (PDF) 01/2020
C-99A Rabies Vaccine VIS: Spanish (PDF) 01/08/2020
C-99A-sup Rabies Vaccine VIS Addendum: Spanish (PDF) 01/2020

Rotavirus Vaccine

Vaccine Information Statements and Addendums Relating to the Rotavirus vaccine
Stock Number Title Revision
C-110 Rotavirus Vaccine VIS: English (PDF) 10/15/2021
C-110-add Rotavirus Vaccine VIS Addendum: English (PDF) 10/2021
C-110A Rotavirus Vaccine VIS: Spanish (PDF) 10/15/2021
C-110A-sup Rotavirus Vaccine VIS Addendum: Spanish (PDF) 10/15/2021

Recombinant Zoster (Shingles) Vaccine

Vaccine Information Statements and Addendums Relating to the Recombinant Zoster (shingles) vaccine.
Stock NumberTitleRevision
C-111Recombinant Zoster (Shingles) Vaccine VIS: English (PDF)
02/04/2022
C-111-add
Recombinant Zoster (Shingles) Vaccine VIS Addendum: English (PDF)
02/2022
C-111ARecombinant Zoster (Shingles) Vaccine VIS: Spanish (PDF)
10/30/2019
C-111A-add
Recombinant Zoster (Shingles) Vaccine VIS Addendum: Spanish (PDF)
10/2019


Td (Tetanus, Diphtheria) Vaccine

Vaccine Information Statements and Addendums Relating to the Td (Tetanus and Diphtheria) vaccine
Stock Number Title Revision
C-94 Td (Tetanus, Diphtheria) Vaccine VIS: English (PDF) 08/06/2021
C-94-add Td (Tetanus, Diphtheria) Vaccine VIS Addendum: English (PDF) 08/2021
C-94A Td (Tetanus, Diphtheria) Vaccine VIS: Spanish (PDF) 08/06/2021
C-94A-sup Td (Tetanus, Diphtheria) Vaccine VIS Addendum: Spanish (PDF) 08/2021

Tdap (Tetanus, Diphtheria, Pertussis) Vaccine

Vaccine Information Statements and Addendums Relating to the Tdap (Tetanus, Diphtheria, and Pertussis) vaccine
Stock Number Title Revision
C-109 Tdap (Tetanus, Diphtheria, Pertussis) Vaccine VIS: English (PDF) 08/06/2021
C-109-add Tdap (Tetanus, Diphtheria, Pertussis) Vaccine VIS Addendum: English (PDF) 08/2021
C-109A Tdap (Tetanus, Diphtheria, Pertussis) Vaccine VIS: Spanish (PDF) 08/06/2021
C-109A-sup Tdap (Tetanus, Diphtheria, Pertussis) Vaccine VIS Addendum: Spanish (PDF) 08/2021

Typhoid

Vaccine Information Statements and Addendums Relating to the Typhoid vaccine
Stock Number Title Revision
EF11-12050 Typhoid VIS - English (PDF) 10/2019
EF11-12050-add Typhoid VIS Addendum - English (PDF) 05/2012
EF11-12050A Typhoid VIS - Spanish (PDF) 05/2012
EF11-12050A-sup Typhoid VIS Addendum - Spanish (PDF) 05/2012

Yellow Fever

Vaccine Information Statements and Addendums Relating to the Yellow Fever vaccine
Stock Number Title Revision
EF11-12051 Yellow Fever VIS - English (PDF) 03/2011
EF11-12051-add Yellow Fever VIS Addendum - English (PDF) 03/2011
EF11-12051A Yellow Fever VIS - Spanish (PDF) 03/2011
EF11-12051A-sup Yellow Fever VIS Addendum - Spanish (PDF) 03/2011
Last updated April 14, 2022